Current state of application of Artificial Intelligence in preoperative MRI assessment of endometrial cancer  a mini review

M. Vasileva; G. Prandzhev; D. Dimitrov; Z. Gorcheva

bg | en

Current state of application of Artificial Intelligence in preoperative MRI assessment of endometrial cancer a mini review

M. Vasileva

, G. Prandzhev

, D. Dimitrov

, Z. Gorcheva

Abstract: Objective: Magnetic resonance imaging (MRI) is valuable for assessment of deep myometrial invasion, cervical stromal involvement and lymph node spread of endometrial cancer for preoperative evaluation of patients` local pelvic status, but recently the application of artificial intelligence (AI) has gained interest over the possibilities it offers for finding more features of MRI images. In this paper we aim to investigate how artificial intelligence is used currently in magnetic resonance imaging for preoperative evaluation of endometrial cancer. Materials and methods: PUBMED archives were searched from 2019 to 2024. The reference lists of included studies and review articles were also searched. Discussion and conclusion: Artificial intelligence has the potential to be integrated into many fields, and healthcare is one of them. This technology is promising especially for future diagnostic imaging practice. Endometrial cancer is one of the most common gynecological malignancies worldwide, and its correct and tailored treatment is essential for the prognosis and quality of life of these women. The use of AI can aid in this process and assist radiologists in preoperative MRI staging, with potential improvements in risk stratification and determination of prognostic factors. Therefore, this new area and its application should be studied.

Series on Biomechanics, Vol.38, No.4(2024),127-132
DOI: 10.7546/SB.17.04.2024

Keywords: Artificial intelligence; endometrial cancer; MRI; preoperative staging

References: (click to open/close)

[1] Siegel RL, Miller KD, Wagle NS, Jemal A., 2023. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians 73, 1,17–48.
[2] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al., 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 7, 3, 209–49.
[3] Wise MR, Jordan V, Lagas A, Showell M, Wong N, Lensen S, et al., 2016. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. American Journal of Obstetrics and Gynecology 214, 6, 689.e1-689.e17.
[4] Karageorgi S, Hankinson SE, Kraft P, De Vivo I., 2010. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses’ Health Study cohort 1976–2004. Int J Cancer 126, 1, 208–16.
[5] Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L., 2005. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30,5, 626–36.
[6] Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al., 2008. Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol. 109, 1, 11–8.
[7] Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, et al., 2009. Sentinel Lymph Node Mapping for Grade 1 Endometrial Cancer: Is it the Answer to the Surgical Staging Dilemma? Gynecol Oncol 113, 2, 163–9.
[8] Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, et al., 2016. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. Journal of Magnetic Resonance Imaging 43, 2,316–24.
[9] Nougaret S, Reinhold C, Alsharif SS, Addley H, Arceneau J, Molinari N, et al., 2015. Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade. Radiology 276, 3,797–808.
[10] Ytre-Hauge S, Dybvik JA, Lundervold A, Salvesen ØO, Krakstad C, Fasmer KE, et al., 2018. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. Journal of Magnetic Resonance Imaging 48, 6, 1637–47.
[11] Jin L, Ma Z, Li H, Gao F, Gao P, Yang N, Li D, Li M, Geng D, 2023. Interobserver Agreement in Automatic Segmentation Annotation of Prostate Magnetic Resonance Imaging. Bioengineering (Basel) 10, 12,1340.
[12] Nougaret S, Tibermacine H, Tardieu M, Sala E, 2019. Radiomics: an Introductory Guide to What It May Foretell. Curr Oncol Rep. 21, 8, 70.
[13] Lecointre L, Dana J, Lodi M, Akladios C, Gallix B, 2021. Artificial intelligence-based radiomics models in endometrial cancer: A systematic review. European Journal of Surgical Oncology 47, 11, 2734–41.
[14] Jojua N, Gognadze T, Dolidze L, 2024. Evaluatin of Medical Doctor program students general general knowledge and perception towards the use of Artificial Intelligence in Medicine. Series on Biomechanics 38, 1, :63-70.
[15] Leo E, Stanzione A, Miele M, Cuocolo R, Sica G, Scaglione M, et al., 2023. Artificial Intelligence and Radiomics for Endometrial Cancer MRI: Exploring the Whats, Whys and Hows. J Clin Med. 13, 1, 226.
[16] Dong HC, Dong HK, Yu MH, Lin YH, Chang CC, 2020. Using Deep Learning with Convolutional Neural Network Approach to Identify the Invasion Depth of Endometrial Cancer in Myometrium Using MR Images: A Pilot Study. Int J Environ Res Public Health. 17, 16, 5993.
[17] Wang X, Deng C, Kong R et al., 2024. Intratumoral and peritumoral habitat imaging based on multiparametric MRI to predict cervical stromal invasion in early-stage endometrial carcinoma. Acad Radiol. S1076-6332(24)00689-5.
[18] Xu X, Li H, Wang S, Fang M, Zhong L, Fan W, Dong D, Tian J, Zhao X, 2019. Multiplanar MRI-Based Predictive Model for Preoperative Assessment of Lymph Node Metastasis in Endometrial Cancer. Front Oncol. 9, 1007.
[19] Frei KA, Kinkel K, 2001. Staging endometrial cancer: Role of magnetic resonance imaging. Journal of Magnetic Resonance Imaging 13, 6, 850–5.
[20] Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al., 2021. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecologic Cancer 1, 1.
[21] Creutzberg CL, Putten WL van, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al., 2000. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. The Lancet 355, 9213, 1404–11.
[22] Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al., 2004. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology 92, 3, 744–51.
[23] Das SK, Niu XK, Wang JL, Zeng LC, Wang WX, Bhetuwal A, et al., 2014. Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis. Cancer Imaging. 14, 1, 32.

DOI: 10.7546/SB.17.04.2024

Date published: 2024-12-11

(Price of one pdf file: 39.00 BGN/20.00 EUR)